USPTO serial 90272202
TRANSIRNA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 2, 2024
- Examiner
- CALLERY, TIMOTHY JOHN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TRANSIRNA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Suwon-si, Gyeonggi-do, KR
SUWON-SI, GYEONGGI-DO, KR
SUWON-SI, GYEONGGI-DO, KR
SUWON-SI, GYEONGGI-DO, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lenny R. Jiang
Lenny R. Jiang PARATUS LAW GROUP, PLLC1765 GREENSBORO STATION PLACE, SUITE 320TYSONS CORNER, VA, 22102UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | preparations for gene recombination for scientific or laboratory purposes; recombinant nucleic acid for scientific or laboratory purposes; nucleic acid for scientific or laboratory purposes; preparations for nucleic acid for scientific or laboratory purposes; oligopeptides for use in the manufacture of cosmetics; peptide substrates for scientific purposes | ACTIVE | — |
| 005 | preparations for gene recombination for medical purposes; oligonucleotides for medical purposes; recombinant nucleic acid for medical purposes; nucleic acid for medical purposes; preparations for nucleic acid for medical purposes; medicated scalp treatments; medicated lotions and creams for the body, skin, face, and hands; medicated creams for treating dermatological conditions; medicated ointments for treating dermatological conditions; medicated lotions for treating dermatological conditions; medicated skin care preparations; pharmaceutical preparations for treating epidermal problems | ACTIVE | — |
| 042 | research and development of technology for biotechnology; scientific research in the fields of biomedicine; pharmaceutical products development; medical studies; medicine research; testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; laboratory research in the field of biology; development of biologics; laboratory research in the field of gene expression; scientific research for medical purposes; research and development of amino acid for medical purposes; research and development of peptide for medical purposes; research and development of oligonucleotides for medical purposes; research and development of technology for medicinal chemical manufacturing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Imnewrun Biosciences, Inc.
- Other trademarks owned by IMNEWRUN, INC.
- Other trademarks owned by IMNEWRUN, INC.
- Other trademarks owned by IMNEWRUN, INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named TRANSIRNA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 2, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 2, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 16, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 16, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 27, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 12, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 29, 2022 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 30, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 30, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 30, 2022 | ALIE | ASSIGNED TO LIE | — |
| Mar 22, 2022 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 8, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 8, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 8, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 14, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 13, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 13, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 24, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 24, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 23, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 10, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 26, 2020 | NWAP | NEW APPLICATION ENTERED | — |